by Kayt Sukel
CRISPR, an innovative new gene editing system, offers great promise to the field of neuroscience—both as a research tool and, potentially, a treatment. Learn more in our new Briefing Paper.
by Philip M. Boffey
How can we reduce the easy availability of opioids that is fueling the epidemic without depriving pain-wracked people of the opioid pain-killers they desperately need? Neuroethics column for Brain in the News.
by Sophie FesslOver thousands of years, tales about using cannabis to treat epilepsy accumulated. The FDA recently approved a solution containing cannabidiol, an ingredient of cannabis, for treating childhood epilepsy. But does cannabidiol live up to expectations?
by Kayt SukelDana
Grantee Liane Young studies
theory of mind, trying to distinguish what in the brain might be off in people
with autism who have trouble with social cues. One of our series of Q&As with neuroscientists.
by Carl ShermanWhile it’s not clear if it is a
cause or an effect, anxiety appears closely linked to circuits affected in
Alzheimer’s and other dementias.
by Kayt SukelResearchers
identify new types of cells--like this rosehip neuron--by looking at the brain through sharper lenses,
searching vast gene expression databases, and crowd-sourcing visual analyses.
by Brenda PatoineWhat happens to the brain of a child who is abused, neglected, or otherwise maltreated? Experts weigh in on this and other questions in our new Briefing Paper.
